Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment

ClinicalTrials.gov ID: NCT06039085

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06039085. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 6:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Microendoscopic Electrical Impedance Sensing for Real-time Intraoperative Surgical Margin Assessment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.

Study identification

NCT ID: NCT06039085
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Ryan J. Halter; Other
Enrollment: 200 participants

Conditions and interventions

Conditions

Prostate Cancer

Interventions

custom device to demonstrate a significant difference in electrical impedance signatures Device

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Male
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 3, 2023 (Actual)
Primary completion: Dec 31, 2026 (Estimated)
Completion: Dec 31, 2027 (Estimated)
Last update posted: Apr 7, 2026

2023 – 2027

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Dartmouth-Hitchcock Medical Center	Lebanon	New Hampshire	03756	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06039085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 7, 2026 · Synced Nov 13, 2026